reported that vitamin D and its metabolites can decrease fibrosis in keloids through vitamin D receptors (VDR) while 1,25 (OH)2 D3 inhibits extracellular matrix deposition and matrix-metalloproteinase activity induced by transforming growth factor (TGF)-β. This evidence concerns the gene TGFB1 and keloid.